Delivery Order SPE2DB22D2211-SPE2DB25FSBYK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,809.30 to AmerisourceBergen Drug Corp for Tacrolimus 0.1% ointment in 30-gram units, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tacrolimus 0.1% ointment in 100-gram quantities under a firm fixed-price contract with a ceiling value of $1,582.61. The order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, to provide Tacrolimus 0.1% ointment in 60 gram tubes. The $13,222.12 delivery order is not associated with any set-aside program and is being issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that allows the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tacrolimus 0.03% Ointment, a specialty medication, with a firm fixed price ceiling value of $1,204.63 and a performance period through April 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $4,726.89, is for the delivery of Tacrolimus 0.1% Ointment in 30 gram quantities. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tacrolimus 0.1% Ointment 60 GM. The contract is a Firm Fixed Price (FFP) agreement with a ceiling value of $4,388.15 and a performance period through February 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tacrolimus 0.1% Ointment, a specialty medication used for various medical conditions. The contract has a ceiling value of $2,823.73 and a period of performance through January 8, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation, indicating...
- This federal contract award, valued at $2,772.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Tacrolimus 0.1% Ointment (60 grams) to DLA Troop Support Medical facilities supporting the Department of Defense. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 100 grams of Tacrolimus 0.1% ointment, a specialty medication used for various medical conditions. The contract has a ceiling value of $6,743.56 and is a firm fixed-price delivery order with a performance period ending on January 22, 2025. The contract is not designated as a set-aside...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,964.62 firm fixed-price delivery order is for the supply of Tacrolimus 0.1% Ointment, 30 grams, with a completion date of January 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBYKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tacrolimus 0.1% Ointment in 100-gram units, with a ceiling value of $1,132.80 and a firm fixed price structure. This award was made without a set-aside designation, indicating open competition. The delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion through December 2026. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This contract represents a routine pharmaceutical supply transaction within the broader context of AmerisourceBergen's role as a primary vendor for the Defense Logistics Agency's medical supply chain. As one of the nation's major pharmaceutical distributors and healthcare solutions providers, AmerisourceBergen maintains extensive federal contracting relationships supporting military and veteran healthcare systems. The SPE2DX master contract vehicle enables the company to supply a comprehensive range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including serving the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/31/25 |